1,345
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia

, , , , , , & show all
Pages 2316-2323 | Received 07 Feb 2023, Accepted 30 Aug 2023, Published online: 21 Sep 2023